Irwin D. Simon

When Is Cannabis Giant Tilray Reporting Earnings And What Should Investors Expect?
Tilray Ramps Up Its Cannabis Portfolio In Canada, Wins International Spirits Competition
Here's Where To Buy Legal Weed While Getting A Tattoo And A Beer: New Cannabis Stores In US And More
Tilray Ramps Up Its Cannabis Portfolio In Canada, Wins International Spirits Competition
Here's Where To Buy Legal Weed While Getting A Tattoo And A Beer: New Cannabis Stores In US And More
Cannabis Giant Tilray Reports 30% YoY Increase In Q3 Net Revenue, Updates FY 2024 Guidance
Tilray's Redecan Launches Spring Lineup As Medical Cannabis Giant Ramps Up Its 'Diversification' Strategy

Irwin D. Simon Recent News

Tilray Brands Q1 Cannabis Revenue Increases 9% QoQ, Narrows Net Loss
Canadian marijuana giant Tilray Brands (NASDAQ: TLRY) (TSX:TLRY), reported its financial results on Wednesday for its first quarter of fiscal year 2024 ended August 31, 2023.
Tilray Completes Acquisition Of 8 Beer Brands From Bud Light Parent Anheuser-Busch
Cannabis company Tilray Brands, Inc. (NASDAQ: TLRY) closed its all-cash 
Tilray CEO Bullish On Beer And Cannabis Legalization, Moves Closer To $4B 'Aspirational Goal'
Tilray Brands (NASDAQ: TLRY) chairman and CEO Irwin D. Simon says his company is set to capitalize on possible cannabis legalization in the U.S. and anticipates creating beer infused with cannabis if/when it becomes legal.
New THC Beverage To Hit Shelves In Nevada Soon, New Frontier In Cannabis Consumption?
Cannabis beverage producer Nevis Brands Inc. (CSE: NEVI) has secured an agreement with Silver State Wellness to produce and distribute Major to Nevada cannabis retailers. Major is a dosable 100mg THC beverage that delivers the effects of cannabis within 10-20 minutes of consumption.
Tilray's New Cannabis Strains By Redecan: Here's Where To Find These Innovative Products
Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) is expanding its market-leading product portfolio by launching new flower genetics by the cannabis lifestyle brand Redecan.
Tilray Ramps Up Pre-Roll Production As Competition Heats Up In Canada
Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) debuted its new 'Diamonds Collection' by its Premium cannabis lifestyle brand RIFF on Wednesday
Canadian Weed Giant Wraps Up Acquisition Of Molson Coors-Backed Cannabis Beverage Producer
Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) has acquired the remaining 57.5% equity ownership of Truss Beverage Co. from beverage company Molson Coors Canada (NYSE: TAP).
Tilray Acquires 8 Beer Brands From Struggling Bud Light Parent Anheuser-Busch: Here's What It Means For Both Companies
Tilray Brands, Inc.
Tilray Brands Stockholders Approve Charter Amendment To Enhance Corporate Governance And Support Strategic Growth Plan
Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) announced that Tilray Brands’ stockholders formally approved an amendment to the company’s certificate of incorporation (the “charter amendment”).
Tilray Q2 Revenue Declines 7% YoY To $144.1M, What About Adjusted EBITDA?
Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY), released financial results for the Q2 2023, revealing net revenue of $144.1 million, a 7% decrease compared to $155.2 million in the Q2 2022.
Independent Proxy Advisory Firms Recommend Tilray Stockholders Vote 'FOR' Tilray's Proposal To Protect Stockholders And Promote Accountability
Tilray Brands, Inc.
Tilray Goes Through With It: Closes $155M Investment In HEXO, Expects $80M In Shared Savings
Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) has closed its acquisition from HT Investments MA LLC (“HTI”) of the secured convertible note issued by HEXO Corp. (NASDAQ: HEXO
HEXO Deal Could Be A Big Win For Tilray, This Analyst Tells Us Why
On Wednesday HEXO Corp (NASDAQ: HEXO) reported a staggering loss of CA$152.7 million ($118 million) in the third quarter of 2022, representing a
Tilray Determined To Resolve Hexo's Debt, Signs Definitive Agreement On Heels Of Earnings
Tilray Brands, Inc.  (NASDAQ: TLRY) confirmed Tuesday it has signed a definitive agreement for a commercial and financial partnership with HEXO Corp.  (NASDAQ: HEXO).
What To Focus On Now After Tilray's Q3 Earnings Report, Analyst Shares Main Takeaways
Irwin Simon, At The Helm Of One Of The Biggest Cannabis Operators, Tilray: Meet Our Keynote Speakers
Who is the person behind the largest Canadian cannabis company in the world? That would be Irwin D. Simon, chairman and CEO of  Tilray Brands Inc. (NASDAQ: TLRY). 
BREAKING: Tilray Brands And HEXO Form Strategic Alliance, Expecting CA$50M Of Cost Synergies In Two Years
HEXO Corp. (TSX:HEXO) (NASDAQ: HEXO) is finalizing a strategic partnership with Tilray Brands, Inc.
Tilray's Revenue Dives 8% QoQ To $155M, Announces New Parent Company Name – Tilray Brands
Tilray, Inc. (NASDAQ: TLRY) (TSX: TLRY) reported Monday its financial results for the second fiscal quarter ended November 30, 2021, with net revenue of $155 million, up by around 20% from $129 million in the same period year ago and 
Will Tilray Stock Continue To Drop? Analyst's Thoughts Ahead Of Q2 Earnings Report
Canadian cannabis giant Tilray Inc. (NASDAQ: TLRY) is scheduled to report its financial results for the second quarter of fiscal 2022 on Monday, Jan. 10, as its stock continues to sink ahead of the event. It was last seen down 1.71% at $6.51.
Tilray Stock Trading Higher On Announcing Acquisition Of Colorado Bourbon Producer
Tilray, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced Wednesday that it is acquiring Breckenridge Distillery. The Canadian cannabis giant expects the transaction to be immediately accretive to EBITDA.
Tilray Launches Fast-Acting Cannabis Oral Strips Across Canada Via Aphria Medical
Canadian cannabis giant Tilray, Inc. (NASDAQ: TLRY) (TSX: TLRY) confirmed Thursday that its medical subsidiary Aphria has launched medical cannabis oral strips in THC and CBD-rich varieties.
The 'New' Tilray: Highlights From First Annual Shareholders Meeting
On Monday, Canadian cannabis giant Tilray, Inc. (NASDAQ: TLRY) (TSX: TLRY) held its first annual meeting of shareholders as the 'new' Ti
Tilray Continues Expanding Its Presence In Europe – Chosen To Supply Luxembourg's Medical Cannabis Program
Tilray, Inc. (TSX: TLRY) (NASDAQ: TLRY) confirmed Tuesday it has been chosen by the Luxembourg Ministry of Health as a supplier of medical cannabis products for the country’s